维普中文期刊产品整合服务
5篇 您的检索式:作者名="Peter Croft"
    题名 作者 年代 出处 被引量
1Inter-observer agreement for Crohn’s disease sub-phenotypes using the Montreal Classification: How good are we? A multi-centre Australasian study显示文摘Krupa Krishnaprasad Jane M. Andrews Ian C. Lawrance Timothy Florin Richard B. Gearry Rupert W.L. Leong Gillian Mahy Peter Bampton Ruth Prosser Peta Leach Laurie Chitti Charles Cock Rachel Grafton Anthony R. Croft Sharon Cooke James D. Doecke Graham L. Rad 2011Journal of Crohn’s and Colitis2011,,3:2
2Employment and Physical Work Activities as Predictors of Future Low Back Pain显示文摘Gary J. Macfarlane Elaine Thomas Ann C. Papageorgiou Peter R. Croft Malcolm I. V. Jayson Alan J. Silman 1997Spine1997,,10:1
3Crohn’s disease and smoking: Is it ever too late to quit?显示文摘Ian C. Lawrance Kevin Murray Birol Batman Richard B. Gearry Rachel Grafton Krupa Krishnaprasad Jane M. Andrews Ruth Prosser Peter A. Bampton Sharon E. Cooke Gillian Mahy Graham Radford-Smith Anthony Croft Katherine Hanigan 2013Journal of Crohn’s and Colitis2013,,:1
4Heahhcare use in adults with insomnia: a longitudinal study显示文摘Richard Hayward Kelvin P Jordan Peter Croft 2010bjgp2010,60,5:1
5Pseudomonas aeruginosa:Infections and novel approaches to treatment“Knowing the enemy”the threat of Pseudomonas aeruginosa and exploring novel approaches to treatment显示文摘Pseudomonas aeruginosa is an aerobic Gram-negative rod-shaped bacterium with a comparatively large genome and an impressive genetic capability allowing it to grow in a variety of environments and tolerate a wide range of physical conditions.This biological flexibility enables the P.aeruginosa to cause a broad range of infections in patients with serious underlying medical conditions,and to be a principal cause of health care associated infection worldwide.The clinical manifestations of P.aeruginosa include mostly health care associated infections and community-acquired infections.P.aeruginosa possesses an array of virulence factors that counteract host defence mechanisms.It can directly damage host tissue while utilizing high levels of intrinsic and acquired antimicrobial resistance mechanisms to counter most classes of antibiotics.P.aeruginosa co-regulates multiple resistance mechanisms by perpetually moving targets poses a significant therapeutic challenge.Thus,there is an urgent need for novel approaches in the development of anti-Pseudomonas agents.Here we review the principal infections caused by P.aeruginosa and we discuss novel therapeutic options to tackle antibiotic resistance and treatment of P.aeruginosa infections that may be further developed for clinical practice.Nikhil Sathe Peter Beech Larry Croft Cenk Suphioglu Arnab Kapat Eugene Athan 2023Infectious Medicine2023,2,3:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费